BIO-key International (NASDAQ:BKYI) Share Price Passes Below Two Hundred Day Moving Average – Should You Sell?

BIO-key International Inc. (NASDAQ:BKYI) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.71 and traded as low as $0.6250. BIO-key International shares last traded at $0.6480, with a volume of 123,447 shares traded.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of BIO-key International to a “sell” rating in a report on Saturday, January 3rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell”.

BIO-key International Price Performance

The stock has a market capitalization of $7.03 million, a PE ratio of -0.62 and a beta of 0.41. The company has a quick ratio of 1.13, a current ratio of 1.26 and a debt-to-equity ratio of 0.17. The stock’s 50-day moving average is $0.62 and its 200 day moving average is $0.71.

Hedge Funds Weigh In On BIO-key International

An institutional investor recently raised its position in BIO-key International stock. Geode Capital Management LLC increased its position in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the period. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 as of its most recent filing with the Securities and Exchange Commission. 26.51% of the stock is currently owned by institutional investors.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.